GlassScriptPhysician profile
Joseph Y Gali
NPI 1437182441
$376.51
in general payments reported to CMS, 2019-2025
8 companies · $16.09 in 2025
The $16.09 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $53.29 · 2021: $35.90 · 2022: $29.73 · 2024: $106 · 2025: $16.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $136.57 | 2019-2022 | |
| Pfizer INC. | $55.44 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $40.59 | 2024 | |
| Sanofi Pasteur INC. | $39.61 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $30.00 | 2019 | |
| Cranial Technologies, INC | $28.47 | 2020-2022 | |
| Seqirus USA INC | $26.14 | 2024 | Flucelvax |
| Dermira, INC. | $19.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.